958 related articles for article (PubMed ID: 23566914)
21. Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid.
Xu S; Wang X; Xu W; Xia Y; Zhang C
Chin Med J (Engl); 2002 Aug; 115(8):1141-5. PubMed ID: 12215278
[TBL] [Abstract][Full Text] [Related]
22. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas--a randomized clinical trial.
Haak CS; Togsverd-Bo K; Thaysen-Petersen D; Wulf HC; Paasch U; Anderson RR; Haedersdal M
Br J Dermatol; 2015 Jan; 172(1):215-22. PubMed ID: 24903544
[TBL] [Abstract][Full Text] [Related]
23. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
24. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy.
Mougel F; Debarbieux S; Ronger-Savlé S; Dalle S; Thomas L
Dermatology; 2009; 219(2):138-42. PubMed ID: 19590166
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Volgin VN; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2012 Sep; 44(7):533-40. PubMed ID: 22851213
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
[TBL] [Abstract][Full Text] [Related]
27. Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial.
Kessels JPHM; Kreukels H; Nelemans PJ; Roozeboom MH; van Pelt H; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Br J Dermatol; 2018 May; 178(5):1056-1063. PubMed ID: 28886209
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
29. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome.
Barolet D; Boucher A
Lasers Surg Med; 2010 Feb; 42(2):171-8. PubMed ID: 20166163
[TBL] [Abstract][Full Text] [Related]
30. Ocular preservation through limited tumor excision combined with ALA-PDT in patients with periocular basal cell carcinoma.
Li X; Tan L; Kou H; Zhang J; Wang Y; Li G; Lu Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():291-294. PubMed ID: 31233885
[TBL] [Abstract][Full Text] [Related]
31. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma.
Venturini M; Sala R; Gonzàlez S; Calzavara-Pinton PG
Br J Dermatol; 2013 Jan; 168(1):99-105. PubMed ID: 23013443
[TBL] [Abstract][Full Text] [Related]
32. Jet-injection assisted photodynamic therapy for superficial and nodular basal cell carcinoma: A pilot study.
Lavin L; Erlendsson AM; Aleissa S; Aleisa A; Menzer C; Dusza S; Cordova M; Alshaikh H; Shah R; Pan A; Ketosugbo K; Hosein S; Lee E; Nehal K; Togsverd-Bo K; Haedersdal M; Rossi A
Lasers Surg Med; 2024 Jul; 56(5):446-453. PubMed ID: 38804170
[TBL] [Abstract][Full Text] [Related]
33. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma.
Smucler R; Vlk M
Lasers Surg Med; 2008 Feb; 40(2):153-8. PubMed ID: 18306163
[TBL] [Abstract][Full Text] [Related]
34. Using photodynamic therapy as a neoadjuvant treatment in the surgical excision of nonmelanotic skin cancers: prospective study.
Jeremic G; Brandt MG; Jordan K; Doyle PC; Yu E; Moore CC
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S82-9. PubMed ID: 21453666
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
36. Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.
Basset-Seguin N; Bissonnette R; Girard C; Haedersdal M; Lear JT; Paul C; Piaserico S
J Eur Acad Dermatol Venereol; 2014 May; 28(5):626-32. PubMed ID: 23581795
[TBL] [Abstract][Full Text] [Related]
37. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT).
Smucler R; Kriz M; Lippert J; Vlk M
Photomed Laser Surg; 2012 Apr; 30(4):200-5. PubMed ID: 22316283
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
[TBL] [Abstract][Full Text] [Related]
40. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
